JP2008523805A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008523805A5 JP2008523805A5 JP2007546589A JP2007546589A JP2008523805A5 JP 2008523805 A5 JP2008523805 A5 JP 2008523805A5 JP 2007546589 A JP2007546589 A JP 2007546589A JP 2007546589 A JP2007546589 A JP 2007546589A JP 2008523805 A5 JP2008523805 A5 JP 2008523805A5
- Authority
- JP
- Japan
- Prior art keywords
- lps
- bordetella
- deacylated
- polypeptide
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002158 endotoxin Substances 0.000 claims 16
- 229920006008 lipopolysaccharide Polymers 0.000 claims 16
- 229920001184 polypeptide Polymers 0.000 claims 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 241000894006 Bacteria Species 0.000 claims 4
- 241000588807 Bordetella Species 0.000 claims 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 241000588832 Bordetella pertussis Species 0.000 claims 3
- 108020004414 DNA Proteins 0.000 claims 3
- 201000005702 Pertussis Diseases 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 208000018150 Bordetella infection Diseases 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229940030156 cell vaccine Drugs 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000020176 deacylation Effects 0.000 claims 1
- 238000005947 deacylation reaction Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 239000000411 inducer Substances 0.000 claims 1
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical class O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000002103 transcriptional effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04078445 | 2004-12-17 | ||
| EP04078445.6 | 2004-12-17 | ||
| PCT/NL2005/050081 WO2006065139A2 (en) | 2004-12-17 | 2005-12-16 | Deacylation of lps in gram negative bacteria |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008523805A JP2008523805A (ja) | 2008-07-10 |
| JP2008523805A5 true JP2008523805A5 (enExample) | 2009-03-26 |
| JP5378685B2 JP5378685B2 (ja) | 2013-12-25 |
Family
ID=34928754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007546589A Expired - Fee Related JP5378685B2 (ja) | 2004-12-17 | 2005-12-16 | グラム陰性菌におけるｌｐｓの脱アシル化 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8048433B2 (enExample) |
| EP (1) | EP1828378B1 (enExample) |
| JP (1) | JP5378685B2 (enExample) |
| CN (1) | CN101203605B (enExample) |
| AU (1) | AU2005317304B2 (enExample) |
| BR (1) | BRPI0519923A8 (enExample) |
| CA (1) | CA2590906C (enExample) |
| DK (1) | DK1828378T3 (enExample) |
| ES (1) | ES2493440T3 (enExample) |
| MX (1) | MX2007007288A (enExample) |
| NO (1) | NO340331B1 (enExample) |
| NZ (1) | NZ555889A (enExample) |
| PL (1) | PL1828378T3 (enExample) |
| PT (1) | PT1828378E (enExample) |
| WO (1) | WO2006065139A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101801997B (zh) * | 2007-03-26 | 2016-06-01 | 由卫生福利和体育大臣代表的荷兰王国 | 基于lps糖基转移酶突变体的改进的抗百日咳博德特氏菌疫苗 |
| SG11201500573RA (en) | 2012-08-06 | 2015-02-27 | Glaxosmithkline Biolog Sa | Method for eliciting in infants an immune response against rsv and b. pertussis |
| US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
| WO2014196887A1 (ru) | 2013-06-04 | 2014-12-11 | Aparin Petr Gennadievich | Модифицированный липополисахарид эндотоксичных бактерий (варианты), комбинация модифицированных липополисахаридов (варианты) и включающие их вакцина (варианты) и фармацевтическая композиция (варианты) |
| US11052142B2 (en) | 2013-06-04 | 2021-07-06 | Petr G. Aparin | Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants) |
| SG11201600709TA (en) | 2013-08-05 | 2016-02-26 | Glaxosmithkline Biolog Sa | Combination immunogenic compositions |
| WO2015179270A2 (en) | 2014-05-19 | 2015-11-26 | Board Of Regents, The University Of Texas System | Combinatorial platform for the display of surface adjuvants and antigens |
| CN104388368B (zh) * | 2014-10-30 | 2017-02-15 | 四川农业大学 | 一株低内毒素大肠杆菌原核表达工程菌突变株及构建方法 |
| EP3408274A1 (en) * | 2016-01-28 | 2018-12-05 | De Staat der Nederlanden, vert. door de minister Van VWS, Ministerie van Volksgezondheid, Welzijn en Sport | Modified tetra-acylated neisserial lps |
| CN105567620B (zh) * | 2016-01-29 | 2019-03-19 | 江南大学 | 一株产减毒类脂A的Cronobacter sakazakii突变株及其应用 |
| CN105695540A (zh) * | 2016-03-18 | 2016-06-22 | 辽宁成大生物股份有限公司 | 一种革兰氏阴性菌胞壁抗原的制备方法 |
| CA3055757A1 (en) * | 2017-03-13 | 2018-09-20 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport | Bordetella vaccines comprising lps with reduced reactogenicity |
| WO2018213242A1 (en) * | 2017-05-15 | 2018-11-22 | University Of Maryland, Baltimore | Live salmonella typhi vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof |
| KR102822764B1 (ko) * | 2017-12-04 | 2025-06-19 | 인트라백 비.브이. | 외막 소포의 생성을 위한 개선된 방법 |
| US20230183656A1 (en) * | 2020-05-14 | 2023-06-15 | Merck Patent Gmbh | Methods and compositions for purifying adeno associated virus particles or adenoviruses |
| US20250263447A1 (en) | 2020-09-04 | 2025-08-21 | Intravacc B.V. | Ompa mutations enhance omv production in bordetella pertussis |
| EP4169513A1 (en) | 2021-10-19 | 2023-04-26 | GlaxoSmithKline Biologicals S.A. | Adjuvant composition comprising sting agonists |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH650681A5 (en) * | 1981-08-14 | 1985-08-15 | Dso Pharmachim | Whooping cough vaccine |
| KR0168039B1 (ko) * | 1987-09-04 | 1999-01-15 | 로버트 디. 웨스트 | 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신 |
| EP0484621A3 (en) * | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
| DE69333467T2 (de) * | 1992-08-18 | 2005-01-20 | Dimminaco Ag | Bordetella bronchiseptica impfstoff |
| PT826001E (pt) * | 1995-05-04 | 2002-12-31 | Aventis Pasteur | Vacinas acelulares contra a tosse convulsa e metodos para a sua preparacao |
| US6887483B2 (en) | 1995-12-01 | 2005-05-03 | University Of Iowa Research Foundation | Non-toxic mutants of pathogenic gram-negative bacteria |
| AU743114B2 (en) * | 1997-04-01 | 2002-01-17 | Corixa Corporation | Aqueous immunologic adjuvant compositions of monophosphoryl lipid A |
| CA2264970A1 (en) * | 1998-03-10 | 1999-09-10 | American Cyanamid Company | Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
| PT1127137E (pt) * | 1998-11-03 | 2007-12-28 | Staat Nl Verteg Door Min Welzi | Lps com toxicidade reduzida a partir de bactérias gramnegativas modificadas geneticamente |
| US6531131B1 (en) * | 1999-08-10 | 2003-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate vaccine for Neisseria meningitidis |
| AU2002307448A1 (en) * | 2001-04-20 | 2002-11-05 | President And Fellows Of Harvard College | Methods and compositions for the modulation of biofilm formation |
-
2005
- 2005-12-16 CN CN200580048420.6A patent/CN101203605B/zh not_active Expired - Fee Related
- 2005-12-16 JP JP2007546589A patent/JP5378685B2/ja not_active Expired - Fee Related
- 2005-12-16 PT PT58154675T patent/PT1828378E/pt unknown
- 2005-12-16 EP EP05815467.5A patent/EP1828378B1/en not_active Expired - Lifetime
- 2005-12-16 ES ES05815467.5T patent/ES2493440T3/es not_active Expired - Lifetime
- 2005-12-16 MX MX2007007288A patent/MX2007007288A/es active IP Right Grant
- 2005-12-16 DK DK05815467.5T patent/DK1828378T3/da active
- 2005-12-16 BR BRPI0519923A patent/BRPI0519923A8/pt not_active Application Discontinuation
- 2005-12-16 CA CA2590906A patent/CA2590906C/en not_active Expired - Fee Related
- 2005-12-16 US US11/722,034 patent/US8048433B2/en not_active Expired - Fee Related
- 2005-12-16 NZ NZ555889A patent/NZ555889A/en not_active IP Right Cessation
- 2005-12-16 AU AU2005317304A patent/AU2005317304B2/en not_active Ceased
- 2005-12-16 PL PL05815467T patent/PL1828378T3/pl unknown
- 2005-12-16 WO PCT/NL2005/050081 patent/WO2006065139A2/en not_active Ceased
-
2007
- 2007-06-18 NO NO20073088A patent/NO340331B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010011868A5 (enExample) | ||
| RU2011142790A (ru) | Адъювантный менингококковый белок, связывающий фактор н | |
| NO20073088L (no) | Deacylering av LPS i gramnegative bakterier | |
| EP2332961A3 (en) | Novel immunogenic compositions for the prevention and treatment of meningococcal disease | |
| WO2003049762A3 (en) | Immunisation against chlamydia trachomatis | |
| JP2007175057A5 (enExample) | ||
| JP2010532656A5 (enExample) | ||
| WO2007048086A3 (en) | Canine influenza virus and related compositions and methods of use | |
| DE60218327D1 (de) | Inaktivierte immunogene bakterielle ganzzell-zusammensetzungen | |
| WO2012009774A3 (pt) | Microrganismos recombinantes, métodos de preparação de linhagens vacinais, antígenos, composições vacinais vetorizadas, seus usos, anticorpos, kit de diagnóstico e métodos de tratamento e/ou profilaxia | |
| BRPI0309001A2 (pt) | bactérias gram-negativas atenuadas | |
| WO2003093307A3 (en) | Mycobacterial antigens and uses thereof | |
| JP6353438B2 (ja) | 微生物の固定化及び脱離方法 | |
| KR100578395B1 (ko) | 면역기능이 강화된 사균화 유산균 제제 및 그 제조방법 | |
| DK1334197T3 (da) | Gær-afledt vaccine mod IPNV | |
| Kotelnikova et al. | Serological analysis of immunogenic properties of recombinant meningococcus IgA1 protease-based proteins | |
| JP2007505836A5 (enExample) | ||
| CN102614504B (zh) | 一种荧光假单胞菌重组蛋白疫苗及其制备 | |
| KR100474967B1 (ko) | 신규한 바실러스속 미생물 및 이를 이용한 2,6-나프탈렌디카르복실산의 정제방법 | |
| ATE466876T1 (de) | Immunogene konstrukte | |
| CN101289650A (zh) | 结核分枝杆菌热休克蛋白Hsp16.3的表达方法 | |
| RU2006123414A (ru) | Белок nmb0928 и его применение в фармацевтических композициях | |
| CN107417773B (zh) | 黏合细胞壁之胜肽 | |
| RU2010152003A (ru) | Композиции и способы применения orf 554 из штаммов бета-гемолитических стрептококков | |
| WO2003031470A3 (de) | Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose |